IDH1 and Increased total leukocyte count: Additionally, treatment with IDH inhibitors can lead to worsening of leukocytosis because of the differentiation syndrome especially during earlier treatment cycles with ≥grade 3 leukocytosis having been reported in 1.7–5% of patients [102,105].